| Management number | 238741259 | Release Date | 2026/07/11 | List Price | US$286.61 | Model Number | 238741259 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Palladia (toceranib phosphate) tablets is an FDA-approved treatment for canine mast cell tumors. It is indicated for Patnaik grades 2 or 3, concurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs. Palladia combines antiangiogenic and antiproliferative properties to kill these tumors by cutting off their blood supply and inhibiting the production of cancerous cells. It’s available by prescription only. Follow your veterinarian’s instructions as prescribed.
| Animal type | Dog |
|---|---|
| Drug brand name | Palladia |
| Medicine strength | 15mg |
| Dosage | Always provide Client Information Sheet with prescription. Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions. Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and app |
| Active ingredients | toceranib phosphate |
| Prescription medicine type | Prescription Medicine |
| Animal health concern | Cancer |
| Pharmacy product status | Active |
| Animal lifestage | All Lifestages |
| Medicine form | Oral |
| Enteral medication form | Tablets |
| Pharmacy product category | BRANDED_RX |
| Container type | Bottle |
| Count per pack | 1 |
| Fda approved for animals | Y |
| Is intended for human consumption | N |
| Shape | Tablet |
| Product net content parent | 60 Each |
| Product net content uom | Each |
| Size | 15 mg |
| Dea class | None/NC (Not Controlled) |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form